CN106729123A - 一种降三高的组合物及其制备方法 - Google Patents
一种降三高的组合物及其制备方法 Download PDFInfo
- Publication number
- CN106729123A CN106729123A CN201710199851.7A CN201710199851A CN106729123A CN 106729123 A CN106729123 A CN 106729123A CN 201710199851 A CN201710199851 A CN 201710199851A CN 106729123 A CN106729123 A CN 106729123A
- Authority
- CN
- China
- Prior art keywords
- composition
- high drop
- raw material
- preparation
- root bark
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 30
- 240000002234 Allium sativum Species 0.000 claims abstract description 11
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 11
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 11
- 241000530115 Clerodendrum trichotomum Species 0.000 claims abstract description 11
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 11
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 11
- 244000241872 Lycium chinense Species 0.000 claims abstract description 11
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 11
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 11
- 240000000249 Morus alba Species 0.000 claims abstract description 11
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 11
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 11
- 244000153955 Reynoutria sachalinensis Species 0.000 claims abstract description 11
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 claims abstract description 11
- 235000009754 Vitis X bourquina Nutrition 0.000 claims abstract description 11
- 235000012333 Vitis X labruscana Nutrition 0.000 claims abstract description 11
- 240000006365 Vitis vinifera Species 0.000 claims abstract description 11
- 235000014787 Vitis vinifera Nutrition 0.000 claims abstract description 11
- 240000008042 Zea mays Species 0.000 claims abstract description 11
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 11
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 11
- 235000005822 corn Nutrition 0.000 claims abstract description 11
- 235000004611 garlic Nutrition 0.000 claims abstract description 11
- 235000008113 selfheal Nutrition 0.000 claims abstract description 11
- 241001128140 Reseda Species 0.000 claims abstract description 10
- 240000000260 Typha latifolia Species 0.000 claims abstract description 10
- 210000000582 semen Anatomy 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 7
- 238000009472 formulation Methods 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 238000004140 cleaning Methods 0.000 claims description 14
- 244000276331 Citrus maxima Species 0.000 claims description 10
- 235000013399 edible fruits Nutrition 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000001802 infusion Methods 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 239000006188 syrup Substances 0.000 claims description 5
- 235000020357 syrup Nutrition 0.000 claims description 5
- 235000014101 wine Nutrition 0.000 claims description 5
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 235000008504 concentrate Nutrition 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 229920000609 methyl cellulose Polymers 0.000 claims description 3
- 239000001923 methylcellulose Substances 0.000 claims description 3
- 235000020097 white wine Nutrition 0.000 claims description 3
- 235000001759 Citrus maxima Nutrition 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims 1
- 235000019890 Amylum Nutrition 0.000 claims 1
- 244000170916 Paeonia officinalis Species 0.000 claims 1
- 235000006484 Paeonia officinalis Nutrition 0.000 claims 1
- 241000405414 Rehmannia Species 0.000 claims 1
- NJDNXYGOVLYJHP-UHFFFAOYSA-L disodium;2-(3-oxido-6-oxoxanthen-9-yl)benzoate Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC([O-])=CC=C21 NJDNXYGOVLYJHP-UHFFFAOYSA-L 0.000 claims 1
- 238000007654 immersion Methods 0.000 claims 1
- 235000010981 methylcellulose Nutrition 0.000 claims 1
- 238000007789 sealing Methods 0.000 claims 1
- 239000013049 sediment Substances 0.000 claims 1
- 235000010413 sodium alginate Nutrition 0.000 claims 1
- 239000000661 sodium alginate Substances 0.000 claims 1
- 229940005550 sodium alginate Drugs 0.000 claims 1
- 238000005303 weighing Methods 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 15
- 239000003814 drug Substances 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 14
- 238000002474 experimental method Methods 0.000 abstract description 10
- 230000036541 health Effects 0.000 abstract description 7
- 206010020772 Hypertension Diseases 0.000 abstract description 6
- 238000002651 drug therapy Methods 0.000 abstract description 3
- 201000001421 hyperglycemia Diseases 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 240000000560 Citrus x paradisi Species 0.000 abstract 1
- 238000012449 Kunming mouse Methods 0.000 description 17
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 230000036772 blood pressure Effects 0.000 description 11
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 238000003304 gavage Methods 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 241000411851 herbal medicine Species 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000035488 systolic blood pressure Effects 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 235000013717 Houttuynia Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 240000007890 Leonurus cardiaca Species 0.000 description 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 241000282806 Rhinoceros Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000009246 art therapy Methods 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Abstract
本发明涉及保健品领域,特别涉及一种降三高的组合物及其制备方法;包括以下按质量份计的原料:赤芍、生地黄、玉米须、地骨皮、桑白皮、黄精、石榴皮、地龙、臭梧桐、夏枯草、稀莶草、茺蔚子、虎杖、绞股蓝、蒲黄、木犀草、向天果、海藻、大蒜、柚子皮、柠檬皮、葡萄皮;本发明配方合理,能有效降低人体高血压、高血糖、高血脂,本发明多年来的试验表明,降三高效果显著,也有效的避免了采用西医手术或药物治疗对患者带来的痛苦,治疗后无副作用,且操作简便,同时所选用的中药原料均容易获得,且对人体没有副作用。
Description
技术领域
本发明保健品领域,特别涉及一种降三高的组合物及其制备方法。
背景技术
“三高症”是指高血压、高血糖和高脂血症,高血压系指循环系统内血压高于正常而言,通常指体循环动脉血压增高,是一种常见的临床综合症,通常是以低于140/90毫米汞柱为正常,而大于等于140/90毫米汞柱为高血压,因它是在不知不觉中发生,故称“悄悄的杀手”;高血脂是指血中胆固醇或甘油三酯过高或高密度脂蛋白胆固醇过低,现代医学称之为血脂异常,它是导致动脉粥样硬化的主要因素,是心脑血管病发生发展的危险因素,它发病隐匿,大多没有临床症状,故称为“隐形杀手”;高血糖是机体血液中葡萄糖含量高于正常值,是机体内一个独立存在的病理改变,病变部位在血液,病变性质是血糖代谢紊乱,高血糖的临床表现,可以有显性的症状,如口干渴、饮水多、尿多、消瘦;可以是隐性的症状,无明显主观不适,三高是现代社会所派生出来的“富贵病”,可能单独存在,也可能相互关联,如:糖尿病人很容易同时患上高血压或高血脂症,而高血脂又是动脉硬化形成和发展的主要因素,动脉硬化患者血管弹性差加剧血压升高,所以,出现这三种疾患中的任何一种,后期都易形成“三高症”。
由于三高跟人们的生活、饮食习惯有很大的关系,前期是没有较为明显的症状的,可是到发现的时候有可能已经形成三高症,目前治疗三高一般采用西医的方法,一般以手术或者药物治疗为主,虽能控制患者的血脂血糖,但只是暂时的,要不断地靠药物来维持,这也加剧了患者的生理系统的负荷,对患者的器官、功能各方面造成难以修复的损伤,还能使得药物在体内残留,严重损害人们的健康,而中医疗法,由于副作用小,见效快,无毒副作用等特点,在三高领域得到快速的发展和推广,目前,对降三高的中药疗法已有大量的研究,并取得一定的疗效,如申请号201610930603.0《一种降三高组合物及其应用》的专利,公开了鱼腥草20~40份、葛根400~600份、西芹50~70份、车钱草10~30份、牛蒡150~250份、芝麻90~110份、核桃5~7份、番茄280~340份、小麦150~250份、养麦80~120份、小米180~220份、大麦20~40份、鹌鹑蛋80~120份、瘦肉80~120份的组分,具有抗血凝、抗血栓、降血脂、降血液粘稠度、软化血管、减少血管病发生、清除体内垃圾及时排出、分解胆固醇、预防胆结石的形成,具有提高大脑机能、活化人体细胞、改善睡眠、延缓衰老、营养全面、保健作用显著等优点。
但是在中药疗法中主要是以中草药为主,通过药物之间的共同作用,实现对三高症的控制,但是,中药组合物之间在具有协同增效的同时,还具有拮抗的作用,而目前的中药疗法中采用的中草药大多存在组分不合理、配比不科学的问题,不但疗效甚微,还有可能通过中草药之间的拮抗作用,对人体进行反侵蚀,造成较大的毒副作用,因此在三高对社会的危害愈来愈严重的当下,有效利用中草药之间的协同增效的作用,研制科学合理,毒副作用小,疗效显著的中药组合物,对三高症进行有效的控制,具有重要的现实意义,同时,也为降三高领域提供一种新思路。
发明内容
本发明为解决上述技术问题,提供了一种降三高的组合物及其制备方法。
具体是通过以下技术方案来实现的:
一种降三高的组合物,包括以下按质量份计的原料:赤芍12~18、生地黄10~20、玉米须8~12、地骨皮15~25、桑白皮3~8、黄精2~4、石榴皮8~12、地龙15~20、臭梧桐4~10、夏枯草12~18、稀莶草6~12、茺蔚子12~18、虎杖10~20、绞股蓝15~25、蒲黄8~12、木犀草12~18、向天果10~20、海藻10~20、大蒜4~8、柚子皮12~18、柠檬皮12~18、葡萄皮15~20。
包括以下按质量份计的原料:赤芍15、生地黄15、玉米须10、地骨皮20、桑白皮5、黄精3、石榴皮10、地龙18、臭梧桐7、夏枯草15、稀莶草9、茺蔚子15、虎杖15、绞股蓝20、蒲黄10、木犀草15、向天果15、海藻15、大蒜6、柚子皮15、柠檬皮15、葡萄皮18。
所述的组合物,是口服制剂,优选为泡酒,胶囊剂、丸剂、片剂、冲剂或糖浆剂。
所述的泡酒,是将原料称取后,洗净后,沥干,加入原料总质量的2~3倍的白酒,密封,夏季至少浸泡25d,冬季至少浸泡35d。
所述的胶囊剂,是将原料称取,洗净后混合,粉碎,再用明胶或甲基纤维素或海藻酸钠制成的空胶囊壳进行包裹,即可。
所述的丸剂,是将原料称取,洗净后混合,粉碎,加水熬煮成含水量为15~20%的浸膏,加入20~30%的预胶化淀粉,拌匀,用75%乙醇浸润,通过造粒机进行造粒,烘干,即可。
所述的片剂,是将原料称取,洗净后混合,粉碎,加入原料质量的20~30%的可压性淀粉,通过压制机压制成片,即可。
所述的冲剂,是将原料称取,洗净后混合,粉碎,加水熬煮成含水量为15~20%的浸膏,自然放置24h,将浸膏烘干,粉碎,包装成小袋即可。
所述的糖浆剂,是将原料称取,洗净后混合,加水煎煮,过滤,将滤液混合,浓缩,再调节浓缩液的含糖量为20~30%,装瓶即可。
综上所述,本发明有益效果在于:本发明配方合理,能有效降低人体高血压、高血糖、高血脂,本发明多年来的试验表明,降三高效果显著,也有效的避免了采用西医手术或药物治疗对患者带来的痛苦,治疗后无副作用,且操作简便,同时所选用的中药原料均容易获得,且对人体没有副作用。
具体实施方式
下面对本发明的具体实施方式作进一步详细的说明,但本发明并不局限于这些实施方式,任何在本实施例基本精神上的改进或代替,仍属于本发明权利要求所要求保护的范围。
实施例1
一种降三高的组合物,包括以下按质量份计的原料:赤芍12g、生地黄10g、玉米须8g、地骨皮15g、桑白皮3g、黄精2g、石榴皮8g、地龙15g、臭梧桐4g、夏枯草12g、稀莶草6g、茺蔚子12g、虎杖10g、绞股蓝15g、蒲黄8g、木犀草12g、向天果10g、海藻10g、大蒜4g、柚子皮12g、柠檬皮12g、葡萄皮15g。
所述的泡酒,是将原料称取后,洗净后,沥干,加入原料总质量的2~3倍的白酒,密封,夏季至少浸泡25d,冬季至少浸泡35d。
实施例2
一种降三高的组合物,包括以下按质量份计的原料:赤芍18g、生地黄20g、玉米须12g、地骨皮25g、桑白皮8g、黄精4g、石榴皮12g、地龙20g、臭梧桐10g、夏枯草18g、稀莶草12g、茺蔚子18g、虎杖20g、绞股蓝25g、蒲黄12g、木犀草18g、向天果20g、海藻20g、大蒜8g、柚子皮18g、柠檬皮18g、葡萄皮20g。
所述的胶囊剂,是将原料称取,洗净后混合,粉碎,再用明胶或甲基纤维素或海藻酸钠制成的空胶囊壳进行包裹,即可。
实施例3
一种降三高的组合物,包括以下按质量份计的原料:赤芍15g、生地黄15g、玉米须10g、地骨皮20g、桑白皮5g、黄精3g、石榴皮10g、地龙18g、臭梧桐7g、夏枯草15g、稀莶草9g、茺蔚子15g、虎杖15g、绞股蓝20g、蒲黄10g、木犀草15g、向天果15g、海藻15g、大蒜6g、柚子皮15g、柠檬皮15g、葡萄皮18g。
所述的丸剂,是将原料称取,洗净后混合,粉碎,加水熬煮成含水量为15~20%的浸膏,加入20~30%的预胶化淀粉,拌匀,用75%乙醇浸润,通过造粒机进行造粒,烘干,即可。
实施例4
一种降三高的组合物,包括以下按质量份计的原料:赤芍12g、生地黄10g、玉米须12g、地骨皮25g、桑白皮3g、黄精2g、石榴皮12g、地龙20g、臭梧桐4g、夏枯草12g、稀莶草12g、茺蔚子18g、虎杖10g、绞股蓝15g、蒲黄12g、木犀草18g、向天果10g、海藻10g、大蒜8g、柚子皮18g、柠檬皮12g、葡萄皮15g。
所述的片剂,是将原料称取,洗净后混合,粉碎,加入原料质量的20~30%的可压性淀粉,通过压制机压制成片,即可。
实施例5
一种降三高的组合物,包括以下按质量份计的原料:赤芍18、生地黄20、玉米须8、地骨皮15、桑白皮8、黄精4、石榴皮8、地龙15、臭梧桐10、夏枯草18、稀莶草6、茺蔚子12、虎杖20、绞股蓝25、蒲黄8、木犀草12、向天果10、海藻20、大蒜4、柚子皮12、柠檬皮18、葡萄皮15。
所述的冲剂,是将原料称取,洗净后混合,粉碎,加水熬煮成含水量为15~20%的浸膏,自然放置24h,将浸膏烘干,粉碎,包装成小袋即可。
实施例6
一种降三高的组合物,包括以下按质量份计的原料:赤芍15g、生地黄10g、玉米须10g、地骨皮15g、桑白皮5g、黄精4g、石榴皮10g、地龙15g、臭梧桐4g、夏枯草18g、稀莶草12g、茺蔚子18g、虎杖20g、绞股蓝15g、蒲黄8g、木犀草12g、向天果10g、海藻20g、大蒜8g、柚子皮18g、柠檬皮18g、葡萄皮15g。
所述的糖浆剂,是将原料称取,洗净后混合,加水煎煮,过滤,将滤液混合,浓缩,再调节浓缩液的含糖量为20~30%,装瓶即可。
实验例
1、毒性试验:
1.1药物:采用实施例1~6的任一组合物。
1.2、试验对象:选取身体状况健康的小白鼠100只,雌雄各半,体重10-15g,在人工照明12h、通风条件良好情况下饲养观察3d,随机分为2组,其中一组为空白对照试组,给药前12h和给药后4小时禁止进食,但不禁水。
1.3、方法:3d过后,除了空白组,对另外一组小白鼠灌服剂量为0.05ml/g、的实施例1~6的任一组合物,观察7d。
1.4、结果:连续观察7d,全部小白鼠均健活且全部小白鼠的精神、食欲、分泌物、呼吸、眼等方面均未观察到异常,将实验昆明鼠和对照组昆明鼠经剖解后,各组织器官无明显感官不同,取心、肝、脾、肺、肾及肠作病理切片也无明显不同,增大剂量,同样的方法灌服实施例1~6的任一组合物,全部昆明鼠仍然健活,且与对照组比较无异常,说明该组合物对昆明鼠安全无毒。
2、血糖实验:
取25±2g的昆明鼠60只,雌雄各半,随机分为对照组、实验组,禁食24h后,对两组昆明鼠按45mg/kg的量灌服四氧嘧啶(或链脲霉素),进行常规饲养,不同之处在于24h,对实验组昆明鼠灌服本发明组合物,对照组昆明鼠灌服市售降血糖药物,为了使实验小鼠糖代谢功能状态尽量保持一致,也为了准确地按体重计算受试样品的用量,实验前两组昆明鼠应严格禁食(不禁水),实验前后禁食条件应一致,昆明鼠在禁食的同时应更换衬垫物,给药后禁食2~4,分别对两组昆明鼠的血糖含量进行测定,结果如表1所示:
表1
3、血压实验:
药品:本实施例1~6任一组合物;
实验体:30±5g的昆明鼠60只,雌雄各半;
实验方法:将小鼠适应性喂养1周后,所有小鼠每天测血压训练1次,待动物适应环境、血压稳定后,随机分为2组,实验组按45mg/kg的量灌服本发明组合物,对照组给予等量蒸馏水;
测量方法:
使用智能无创血压计进行清醒状态下小鼠尾动脉间接测压,分别测定各组给药前及给药后10、30、60、180、300min后的收缩压,每个时间点连续测3次计算平均值,收缩压以mmHg表示,结果如表2所示:
表2
项目 | 实验组 | 对照组 |
给药前收缩压 | 135.8±2.5 | 135.8±2.5 |
给药10min后收缩压 | 127.3±8.7 | 134.8±4.3 |
给药30min后收缩压 | 118.6±3.6 | 133.8±5.2 |
给药60min后收缩压 | 116.3±4.5 | 134.8±6.2 |
给药180min后收缩压 | 125.8±2.2 | 134.6±3.8 |
给药300min后收缩压 | 134.7±5.8 | 135.1±1.8 |
说明:给药10min血压下降明显,给药30min血压持续下降,给药60min血压降至最低值,其降压作用维持较长,给药180min后血压略有回升,但血糖含量还是较给药前低,仍有一定降压作用,给药300min血压基本恢复到给药前水平,本发明组合物具有较为明显的降血压的作用。
4、血脂实验:
取18~22g的昆明鼠60只,雌雄各半,随机分为对照组、实验组,对两组昆明鼠进行常规饲养,两组昆明鼠喂服的饲料是高脂饲料,其组成为基础饲料80%,蛋黄粉4%,猪油6%,胆固醇10%,各组小鼠自由采食,光照温度适宜,不同之处在于,实验组昆明鼠灌服本发明组合物,对照组昆明鼠灌服相同剂量的蒸馏水,每日给药前,对小鼠称重,计算各组小鼠体重平均值,每日灌服两次,每次灌服量为30mg/kg,实验时间为三周,实验结束前一天,所有小鼠禁食24h,分别对两组昆明鼠的血清甘油三酯和总胆固醇水平进行测定,结果如表3所示:
表3
项目 | 总胆固醇mmol/L | 甘油三酯mmol/L |
实验组 | 5.23±0.015 | 0.52±0.023 |
对照组 | 7.12±0.028 | 0.87±0.014 |
本发明组合物对降低血液中的总胆固醇和甘油三酯,效果显著。
Claims (9)
1.一种降三高的组合物,其特征在于,包括以下按质量份计的原料:赤芍12~18、生地黄10~20、玉米须8~12、地骨皮15~25、桑白皮3~8、黄精2~4、石榴皮8~12、地龙15~20、臭梧桐4~10、夏枯草12~18、稀莶草6~12、茺蔚子12~18、虎杖10~20、绞股蓝15~25、蒲黄8~12、木犀草12~18、向天果10~20、海藻10~20、大蒜4~8、柚子皮12~18、柠檬皮12~18、葡萄皮15~20。
2.如权利要求1所述的降三高的组合物,其特征在于,包括以下按质量份计的原料:赤芍15、生地黄15、玉米须10、地骨皮20、桑白皮5、黄精3、石榴皮10、地龙18、臭梧桐7、夏枯草15、稀莶草9、茺蔚子15、虎杖15、绞股蓝20、蒲黄10、木犀草15、向天果15、海藻15、大蒜6、柚子皮15、柠檬皮15、葡萄皮18。
3.如权利要求1所述的降三高的组合物,其特征在于,所述的组合物,是口服制剂,优选为泡酒,胶囊剂、丸剂、片剂、冲剂或糖浆剂。
4.如权利要求3所述的降三高组合物的制备方法,其特征在于,所述的泡酒,是将原料称取后,洗净后,沥干,加入原料总质量的2~3倍的白酒,密封,夏季至少浸泡25d,冬季至少浸泡35d。
5.如权利要求3所述的降三高组合物的制备方法,其特征在于,所述的胶囊剂,是将原料称取,洗净后混合,粉碎,再用明胶或甲基纤维素或海藻酸钠制成的空胶囊壳进行包裹,即可。
6.如权利要求3所述的降三高组合物的制备方法,其特征在于,所述的丸剂,是将原料称取,洗净后混合,粉碎,加水熬煮成含水量为15~20%的浸膏,加入20~30%的预胶化淀粉,拌匀,用75%乙醇浸润,通过造粒机进行造粒,烘干,即可。
7.如权利要求3所述的降三高组合物的制备方法,其特征在于,所述的片剂,是将原料称取,洗净后混合,粉碎,加入原料质量的20~30%的可压性淀粉,通过压制机压制成片,即可。
8.如权利要求3所述的降三高组合物的制备方法,其特征在于,所述的冲剂,是将原料称取,洗净后混合,粉碎,加水熬煮成含水量为15~20%的浸膏,自然放置24h,将浸膏烘干,粉碎,包装成小袋即可。
9.如权利要求3所述的降三高组合物的制备方法,其特征在于,所述的糖浆剂,是将原料称取,洗净后混合,加水煎煮,过滤,将滤液混合,浓缩,再调节浓缩液的含糖量为20~30%,装瓶即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710199851.7A CN106729123A (zh) | 2017-03-29 | 2017-03-29 | 一种降三高的组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710199851.7A CN106729123A (zh) | 2017-03-29 | 2017-03-29 | 一种降三高的组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106729123A true CN106729123A (zh) | 2017-05-31 |
Family
ID=58966678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710199851.7A Pending CN106729123A (zh) | 2017-03-29 | 2017-03-29 | 一种降三高的组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106729123A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108497392A (zh) * | 2018-05-29 | 2018-09-07 | 闫峻峰 | 一种预防高血糖高血压的食品 |
CN110604787A (zh) * | 2019-09-17 | 2019-12-24 | 江苏医盟健康科技有限公司 | 一种治疗高血压的药物及其制备方法 |
CN114796404A (zh) * | 2022-06-14 | 2022-07-29 | 重庆四福九瑞科技有限公司 | 一种降三高的中药组合物及其使用方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104107349A (zh) * | 2014-07-01 | 2014-10-22 | 河南科技大学第一附属医院 | 一种“三高症”病人用中草药及其服用方法 |
-
2017
- 2017-03-29 CN CN201710199851.7A patent/CN106729123A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104107349A (zh) * | 2014-07-01 | 2014-10-22 | 河南科技大学第一附属医院 | 一种“三高症”病人用中草药及其服用方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108497392A (zh) * | 2018-05-29 | 2018-09-07 | 闫峻峰 | 一种预防高血糖高血压的食品 |
CN110604787A (zh) * | 2019-09-17 | 2019-12-24 | 江苏医盟健康科技有限公司 | 一种治疗高血压的药物及其制备方法 |
CN114796404A (zh) * | 2022-06-14 | 2022-07-29 | 重庆四福九瑞科技有限公司 | 一种降三高的中药组合物及其使用方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101940620B (zh) | 一种治疗糖尿病的药物组合物及其应用 | |
CN109393494A (zh) | 一种中老年用保健食品组合物及其应用 | |
CN106729123A (zh) | 一种降三高的组合物及其制备方法 | |
KR20130063074A (ko) | 당뇨병과 당뇨합병증의 혈당 혈압 저하작용 조성물 | |
CN105028995A (zh) | 一种配合狗粮及其制备方法 | |
CN107136281A (zh) | 一种用于改善女性肾功能的昆布虫草压片糖果及其制备方法 | |
CN103735623A (zh) | 辅助降血脂片 | |
CN101773624A (zh) | 一种用于治疗糖尿病的中药组合物及其制备方法 | |
CN105101817B (zh) | 可食用组合物及其制备方法和包含该组合物的食品 | |
CN109771578A (zh) | 防治糖尿病及并发症的组合物 | |
CN101904501A (zh) | 一种缓解疲劳的功能食品及其制备方法 | |
CN1990033A (zh) | 一种治疗高血压、血稠、动脉硬化的药物 | |
CN104324134B (zh) | 一种改善微循环的中药组合物及其制备方法 | |
CN103720808B (zh) | 一种具有通便功效的组合物及其用途、制备方法 | |
CN103798596B (zh) | 一种供心脑血管疾病患者食用的全营养配方食品 | |
CN102552743A (zh) | 一种用于治疗糖尿病的药物组合物及其制备方法 | |
CN103877554B (zh) | 一种治疗心脏病的药物组合物及其制备方法和用途 | |
CN103181557A (zh) | 具有减肥功能的营养食品及其制备方法 | |
CN102335362B (zh) | 一种治疗2型糖尿病胰岛素抵抗的中药 | |
CN105733880A (zh) | 一种以榛子粕为原料酿制的复合榛子酒 | |
CN106109951A (zh) | 防治高血糖、高血脂、高血压的药物及其制备方法 | |
CN105211418A (zh) | 一种补心的养生茶冲剂及其制备方法 | |
CN100455317C (zh) | 治疗2型糖尿病的药物 | |
CN1299732C (zh) | 治疗脂肪肝的中药制剂 | |
CN103859393B (zh) | 一种食品及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170531 |